SCHEMBL7786167

SCHEMBL7786167

O=C1c2ccc(OCCC3CCCCN3)cc2-c2c(OCCC3CCCCN3)cccc21

nearest known ligand 0.43

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.43
CHEK2 O96017 1/20 0.39
PIM1 P11309 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
LTA4H P09960 4/20 0.37
SSTR2 P30874 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7786404 0.97 KCNA3 (0.44) KCNA3
SCHEMBL7786024 0.92 MAPT (0.40) KCNA3CHEK2SSTR2
SCHEMBL7786049 0.91 MAPT (0.44) KCNA3CHEK2SSTR2
SCHEMBL7795713 0.90 MAPT (0.40) PIM1PIM2SSTR2
SCHEMBL7792037 0.89 CHRNB4 (0.41) KCNA3PIM1PIM2SSTR2
SCHEMBL7792423 0.89 CHRNB4 (0.38) KCNA3
SCHEMBL7786141 0.88 MAPT (0.42) KCNA3
SCHEMBL7792188 0.87 MAPT (0.42) KCNA3
SCHEMBL7796472 0.87 TTR (0.41) KCNA3
SCHEMBL7792462 0.86 KCNA3 (0.40) KCNA3CHEK2PIM1PIM2SSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906268-B1 ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS AVENTIS PHARMA INC (US) 2001-11-28 EP disclosed
US-6004959-A HYPOTENSIVE, ANTITUMOR, ANTIINFLAMMATORY AND ANTIASTHMATIC AGENTS; ANGIOGENESIS AND ALVEOLAR MACROPHAGE ACTIVATION INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1999-12-21 US disclosed
EP-0906268-A1 ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1999-04-07 EP disclosed
WO-1997045397-A1 ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1997-12-04 WO disclosed